SIC 3845 – Electromedical and Electrotherapeutic Apparatus
Valuation | |
---|---|
Market Cap ($M) | 89.06 |
Enterprise Value ($M) | 68.41 |
Book Value ($M) | 20.76 |
Book Value / Share | 0.38 |
Price / Book | 4.29 |
NCAV ($M) | -1.97 |
NCAV / Share | -0.04 |
Price / NCAV | -45.12 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.62 |
Return on Assets (ROA) | -0.58 |
Return on Equity (ROE) | -0.67 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 4.03 |
Current Ratio | 4.03 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 23.06 |
Assets | 45.80 |
Liabilities | 25.04 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -26.96 |
Net Income | -25.65 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -23.70 |
Cash from Investing | -0.89 |
Cash from Financing | 0.13 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Williams Gregg | 38.90 | ||
13D | Bolck Joachim Eberhard | 11.03 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
12,753 | 45,383 | 28.10 | |
6,091 | 33,478 | 18.19 | |
12,710 | 8,860 | 143.45 | |
35,203 | 15,676 | 224.57 | |
(click for more detail) |
Similar Companies | |
---|---|
TNON – Tenon Medical, Inc. | TTOO – T2 Biosystems, Inc. |
UFPT – UFP Technologies, Inc. | VERO – Venus Concept Inc. |
VVOS – Vivos Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io